ArticleActa pharmaceutica Sinica. B2025

Non-blocking anti-PD-L1 nanobody conjugated to TLR7 agonist mediates macrophage/NK cell-associated antitumor effects.

Chao Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.